ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 933,22
-0,65%
Dow Jones
37 903,29
0,00%
DAX
17 946,83
0,14%
Brent Oil
83,995
0,54%
Bitcoin
58 731,43
0,85%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Merus NV (MRUS)

  7. Merus NV (MRUS) Actualités

MRUS Merus NV

47,02
0,00 (0,00%)
Avant marché
Dernière mise à jour : 13:00:08
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Merus NV MRUS NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 47,02 13:00:08
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
47,02
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
08/4/202418:00GLOBEMerus Presents Preclinical Data Demonstrating Efficacy of..
03/4/202414:00GLOBEMerus to Participate in a Fireside Chat at the 23rd Annual..
06/3/202414:15EDGAR2Form 8-K - Current report
06/3/202414:00BWGilead and Merus Announce Collaboration to Discover Novel..
05/3/202422:30GLOBEMerus Announces Publication of an Abstract for Presentation..
04/3/202414:00GLOBEMerus to Participate in a Fireside Chat at the Leerink..
28/2/202422:55EDGAR2Form S-3ASR - Automatic shelf registration statement of..
28/2/202422:15GLOBEMerus Announces Financial Results for the Fourth Quarter and..
14/2/202422:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31/1/202414:00GLOBEMerus to Participate in Upcoming Investor Conferences
20/12/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202323:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202301:29EDGAR2Form 144 - Report of proposed sale of securities
12/12/202322:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/12/202302:40GLOBEMerus Presents Interim Data on MCLA-129 at ESMO Asia..
01/12/202316:47EDGAR2Form 144 - Report of proposed sale of securities
26/11/202317:05GLOBEMerus Announces Publication of Abstracts on MCLA-129 for..
02/11/202321:12GLOBEMerus Announces Financial Results for the Third Quarter 2023..
02/11/202321:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202313:00GLOBEMerus to Participate in Upcoming Investor Conferences
23/10/202313:30GLOBEMerus’ Zeno Interim Data Continues to Demonstrate Robust and..
16/10/202301:58GLOBEMerus Announces Business Update Conference Call
11/10/202322:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202322:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/10/202315:32GLOBEMerus Announces Abstracts Accepted for Presentation at the..
31/8/202314:00GLOBEMerus to Participate in Upcoming Investor Conferences
11/8/202322:01EDGAR2Form 8-K - Current report
11/8/202315:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/8/202303:53GLOBEMerus Announces Pricing of Public Offering of Common Shares
09/8/202322:07EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
09/8/202322:01GLOBEMerus N.V. Announces Proposed Public Offering of Common..
07/8/202322:26GLOBEMerus Announces Financial Results for the Second Quarter..
07/8/202322:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
28/7/202314:00GLOBEMerus Announces Two Clinical Abstracts on Zenocutuzumab..
05/7/202322:01GLOBEZenocutuzumab (Zeno) granted second Breakthrough Therapy..
29/6/202322:30GLOBEZenocutuzumab (Zeno) granted Breakthrough Therapy..
15/6/202313:47GLOBEMerus Appoints Life Sciences Strategic and Financial..
31/5/202314:00GLOBEMerus to Participate in a Fireside Chat at the Jefferies..
04/5/202322:25GLOBEMerus Announces Financial Results for the First Quarter 2023..

Dernières Valeurs Consultées

NASDAQ
MRUS
Merus NV
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés